TrialThe lancet. Diabetes & endocrinology2018

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.

Kenneth G Saag et al.PubMed ↗Publisher ↗

No numbers read from the abstract.